Cannabis is the most commonly used illicit substance worldwide, and cannabis use disorders (CUDs) are correspondingly high. Increased demand for treatment and relatively low rates of positive clinical outcomes has led to a large scientific investment in the development of interventions for the treatment of CUD. Much of this research is conducted with cannabis users who are not seeking treatment at the time of study participation, and it is unknown whether these individuals are representative of those who seek treatment. This study contrasted samples of cannabis users participating in screening interviews for treatment and nontreatment research studies. Several differences between groups emerged: Treatmentseekers were more likely to be female (43% vs. 29%), older (33.4 vs. 29.7 years), and have longer cannabis use histories compared with non-treatment-seekers (p ϭ .007). Treatment-seekers were more likely to report experiencing guilt after using cannabis and to feel that cannabis use has been a problem for them. Additionally, treatment-seekers reported a greater mean number of reasons for making a quit attempt, experiencing a greater number of withdrawal symptoms, and employing more coping strategies during prior quit attempts. Despite the aforementioned differences, the 2 groups were similar on several key characteristics, particularly with regards to current levels of cannabis use and related problems.
Cannabis continues to be the most widely used illicit substance in the world (UNODC, 2012; WHO, 2014) . Cannabis use disorders (CUD) are relatively prevalent worldwide, and were recently estimated to occur in approximately 9% of cannabis users in the United States (Meier et al., 2012) . The number of individuals seeking treatment for CUD has been increasing in the United States, Europe, and Australia (SAMHSA, 2010; EMCDDA, 2008; NCPIC, 2012) .
Clinical research has demonstrated that a variety of evidencebased psychosocial therapies are effective treatments for CUD, including motivational interviewing (MI), cognitive-behavioral therapy (CBT), and contingency management (CM; Davis et al., 2014) . Despite this, most individuals who enter treatment fail to achieve sustained periods of abstinence despite having a reported desire to quit (Budney, Roffman, Stephens, & Walker, 2007; Davis et al., 2014 ). An expanding portfolio of research is being conducted to improve understanding of cannabis use, consequences, and cessation with the aim of improving treatment outcomes.
Much of this research is conducted with frequent cannabis users who are not seeking treatment at the time of study participation. Examples include early Phase I/II trials of medications that are potential pharmacotherapies and laboratory studies designed to model craving, withdrawal, drug self-administration and relapse. While essential for cost-effective evaluation and development, little research has been conducted to evaluate whether the nontreatment-seeking cannabis users who volunteer for these studies are representative of the population that presents for treatment.
Research with other substances of abuse has been conducted to explore demographic similarities and differences between samples of treatment-seeking and non-treatment-seeking research participants. Findings indicate that treatment-seeking and non-treatmentseeking samples are largely similar, with some noteworthy differences.
Briefly, Carroll and Rounsaville (1992) and Smith, Dent, Coles, and Falek (1992) found that treatment-and non-treatment-seeking cocaine users were comparable on measures of severity of cocaine use, though non-treatment-seeking cocaine users tended to experience fewer problems and negative consequences as a result of their drug use. Rounsaville and Kleber (1985) explored differences between opiate-dependent individuals seeking treatment versus those not seeking treatment and found that while both treatmentseeking and non-treatment-seeking participants were similar on duration and severity of opiate use, non-treatment-seekers tended to report more adequate social functioning and fewer problems related to their substance use.
Though published reports are available that characterize samples of treatment-seeking cannabis users (Copeland, Swift, & Rees, 2001; Stephens, Babor, Kadden, Miller, & the Marijuana Treatment Project Research Group, 2002; Stephens, Roffman, & Simpson, 1993; Strike, Urbanoski, & Rush, 2003) and non-treatment-seeking cannabis users (Buchowski et al., 2011; Copersino et al., 2006a; Copersino et al., 2006b; Levin et al., 2010; Stein, Hagerty, Herman, Phipps, & Anderson, 2011) , no studies have provided a direct comparison of these two groups. The present study was conducted to perform such a comparison in order to identify unique characteristics of those who seek treatment, and also evaluate the degree to which research volunteers for laboratory-based clinical research studies are representative of those who seek formal treatment.
Method Participants
Participants represent a cohort of volunteers who were evaluated for laboratory and clinical research studies of cannabis at the Johns Hopkins University Behavioral Pharmacology Research Unit (BPRU) between November 2008 and November 2013. The BPRU is a broad-based substance abuse clinical research program located in Baltimore, Maryland that encompasses both human laboratory research and outpatient treatment research for a variety of legal and illegal substances. The laboratory studies included in this evaluation consisted of residential studies lasting between 20 and 52 days in duration, requiring between 13 and 52 residential nights (Vandrey, Smith, McCann, Budney, & Curran, 2011; Vandrey et al., 2013) . The clinical study involved participation in a 12-week outpatient treatment program (currently ongoing). All studies included administration of investigational medications (i.e., dronabinol, zolpidem), and the residential studies involved cannabis selfadministration.
All study volunteers were screened over the telephone for initial research eligibility prior to completing clinical interviews and assessments in person.
Participation was limited to current cannabis users (verified via urine toxicology test) between the ages of 18 and 55 who were physically healthy and reported experiencing withdrawal during prior periods of abstinence. In total, 205 volunteers were evaluated for research eligibility. Of those, 74 wanted to quit/reduce their cannabis use and were seeking formal treatment and 131 were volunteering for paid research participation and expressed no desire to stop or reduce cannabis use.
Assessments
The Marijuana Quit Questionnaire (MJQQ; Boyd et al., 2005; Copersino et al., 2006a ) was administered to all participants using pencil and paper during the intake assessment. The MJQQ is a 176-item, individually administered, self-report questionnaire that collects data on demographic information, cannabis use history, and information about prior attempts to quit cannabis use including: reasons for quitting and resuming use; coping strategies used while quitting (Boyd et al., 2005) ; withdrawal symptoms experienced (yes/no) during quit attempts, and intensity of experienced symptoms (1 ϭ very little to 5 ϭ very high) (Copersino et al., 2006a) ; and substance use prior to and during quit attempts.
Within the MJQQ, participants were given a list of 26 potential reasons for quitting cannabis use, and were asked to rate the extent to which each reason matched their personal reasons for initiating their most difficult prior quit attempt using a scale from 0 to 4 (0 ϭ not at all, 1 ϭ a little, 2 ϭ moderately, 3 ϭ quite a bit, 4 ϭ extremely/very much). Dichotomous variables were created based on these possible response options ("not at all" vs. "a little or greater").
Participants also rated the extent to which their most difficult prior quit attempt affected their consumption of other legal and illegal substances. To assess reasons for cannabis relapse, participants were asked "Why did you start smoking cannabis again after your quit attempt?" and asked to select all that applied from a list of 28 potential reasons.
Before answering questions related to the "most difficult" quit attempt, participants were presented with the following: "Now think of the most difficult time you had intentionally stopping all marijuana use (while not in a controlled environment such as jail or hospital). Please answer all the following questions only as related to that quit attempt. If more than one quit attempt was of the same difficulty, please use the longest quit attempt.
Statistical Analyses
The sample was restricted to individuals who had made a quit attempt at some point in their lives [83% of non-treatment-seekers (131/158) and 86% of treatment-seekers (74/86)], leaving a total sample of 205 current cannabis users for the present analyses. Statistical significance of differences between treatment-seeking and non-treatment-seeking cannabis users on the basis of sociodemographic and cannabis use history, quit attempt characteristics, reasons for attempting to quit, use of coping strategies, substance use, and reasons for resuming cannabis use was established using t tests for comparisons of means and chi-square ( 2 ) tests for comparisons of categorical data. Analyses of use of substances other than cannabis were limited to individual substances endorsed by 5% or more of the sample. All analyses were completed using STATA version 13.0 statistical software (StataCorp, 2013) .
Results

Sociodemographic and Cannabis Use History Characteristics
Participant characteristics are shown in Table 1 . Treatment seekers were more likely to be female 2 (1, n ϭ 205) ϭ 4.26, p ϭ .039 and were older than non-treatment-seeking participants, t(201) ϭ Ϫ2.7406, p ϭ .007. Despite initiating first cannabis use (p ϭ 0.860) and frequent cannabis use (p ϭ .712) at similar ages, treatment seekers had longer histories of overall use, t(201) ϭ Ϫ2.7348, p ϭ .007 and frequent use, t(201) ϭ -2.6145, p ϭ .010, likely reflective of the age difference between the two samples.
Additionally, treatment-seeking participants were more likely to report feeling guilt or remorse following cannabis use 2 (1, n ϭ 205) ϭ 7.11, p ϭ .008), as well as to report feeling that cannabis use has been a problem for them at some point during their lives ( 2 (1, n ϭ 205) ϭ 31.20, p Ͻ .001). Conversely, non-treatmentseekers reported smoking more blunts (i.e., cannabis cigarettes rolled using cigar paper) during an average 24-hour period prior to their previous "most difficult" quit attempt than did treatment seekers, t(197) ϭ 3.3577, p Ͻ .001. No significant differences were observed between treatment seekers and non-treatment-seekers on the basis of DSM-IV-TR (APA, 2000) criteria for cannabis abuse or dependence (p ϭ .507).
Characteristics of Prior Attempts to Quit
Characteristics of quit attempts are shown in Table 2 . Treatment seekers and non-treatment-seekers reported making a similar number of lifetime quit attempts (p ϭ 0.087), and similar proportions from each group reported a past-year quit attempt (p ϭ 0.260).
During prior quit attempts, treatment seekers reported having achieved a significantly longer period of complete abstinence compared with non-treatment-seekers, t(201) ϭ Ϫ5.2724, p Ͻ .001. When reporting about their most difficult prior quit attempt, treatment seekers reported a significantly greater number of withdrawal symptoms, t(191) ϭ Ϫ5.5454, p Ͻ .001 and having engaged in that quit attempt more recently, t(201) ϭ 2.1845, p ϭ .030 than non-treatment-seekers.
Reasons for the Quit Attempt
Reasons for attempting to quit cannabis use are shown in Table  3 . The most commonly endorsed reasons for initiating a quit attempt were "To save the money that I spent on cannabis" (78.2%), "To prove to myself that I wasn't addicted" (60.4%), and "So that I could feel in control of my life" (56.3%). Conversely, reasons such as "I knew other people who had health problems caused by cannabis" (12.2%), "I was worried that cannabis use would shorten my life" (17.3%), "To avoid a conviction or jail sentence" (19.3%) and "Someone gave me an ultimatum" (19.8%) were less commonly endorsed. When comparing the two groups, treatment seekers were significantly more likely to endorse a variety of individual reasons for quitting (see Table 3 ), and, on average, endorsed a significantly greater number of reasons than non-treatment-seekers, t(203) ϭ Ϫ3.1074, p ϭ .002. Items with the greatest disparity between individuals seeking treatment compared with non-treatment seekers tended to relate to self-image and positive life change (e.g., would like myself better, want to get control of life, to increase energy, be more productive during the day, be a good example for children).
Coping Strategies
Characteristics of the coping strategies reported by cannabis users during their most difficult quit attempt can be found in Table 4 . Common coping strategies reportedly used during quit attempts included getting rid of cannabis (58.1%) and getting rid of cannabis paraphernalia (46.0%), while medical or counseling approaches, such as attending self-help groups, counseling/therapy, physician care, prescription and nonprescription medication, herbal medicine, and acupuncture were much less commonly reported (Ͻ10%). Treatment seekers reported utilizing significantly more coping strategies during their quit attempt than did nontreatment-seekers, t(190) ϭ Ϫ3.1154, p ϭ .0021. With regard to individual coping strategies, treatment seekers were significantly more likely to report that they "stopped associating with people who smoke cannabis" 2 (1, n ϭ 198) ϭ 5.37, p ϭ .021; "stopped going places where cannabis was smoked" 2 (1, n ϭ 199) ϭ 4.20, p ϭ .041; "got rid of my cannabis paraphernalia" 2 (1, n ϭ 198) ϭ 5.50, p ϭ .019; "attended a self-help group" 2 (1, n ϭ 198) ϭ 8.24, p ϭ .014; and "got counseling/psychotherapy" 2 (1, n ϭ 198) ϭ 13.35, p Ͻ .001) compared with nontreatment-seekers.
Substance Use
Self-reported substance use can be found in Table 5 . During the 6 months prior to participants' most difficult quit attempt, reported use of caffeine, alcohol, tobacco, and non-narcotic pain medications did not differ by treatment-seeking status. However, treatment seekers were more likely to report increasing their use of 
Reasons for Resuming Use
All participants were current cannabis users at the time these assessments were conducted, and had thus resumed use of cannabis following their most difficult prior quit attempt. The most commonly endorsed reasons for resuming cannabis use following the most difficult prior quit attempt were "to relax" (78.7%), "to sleep better" (70.0%), "because I was craving cannabis" (69.5%), and "I missed feeling 'high'" (69.5%). Treatment seekers were more likely to report "to feel less depressed" ( 2 (1, n ϭ 197) ϭ 6.20, p ϭ .013) and "to sleep better" ( 2 (1, n ϭ 197) ϭ 4.34, p ϭ .037) as reasons for relapse compared with non-treatment-seekers.
Discussion
The present study compared demographic and substance use characteristics of current cannabis users seeking treatment with those volunteering for non-treatment-based laboratory studies. Treatment seekers tended to be older, a finding that is not surprising given prior research showing associations between older age and treatment-seeking behavior (Mojtabai, Olfson, & Mechanic, 2002) . Treatment seekers were also more likely to be female, but were still a minority relative to males in both groups. Prior research indicates that females are less likely to seek substance use treatment due to multiple access-related barriers (Green, 2006) , so it is possible that this difference reflects a gender difference in willingness to participate in residential research studies. Because the reported age of cannabis use initiation and age that frequent cannabis use began were similar across study groups, the outcome that treatment seekers had longer histories of use and frequent use compared with non-treatment-seekers likely reflects the age difference between the two groups.
With regard to experiences during prior quit attempts, treatment seekers were reportedly able to stay quit for a longer period of time than non-treatment-seekers before resuming cannabis use and reported making a quit attempt more recently than non-treatmentseekers. Treatment seekers reported experiencing a greater number of withdrawal symptoms during abstinence on average and endorsed a greater number of reasons for making a quit attempt. The former finding could indicate a greater degree of impairment during abstinence resulting in motivation to quit and entry into treatment-based studies, while the latter further points to an increased motivation to quit using cannabis. Despite these differences, the two groups were similar in terms of several key characteristics. Treatment-and non-treatmentseekers reported comparably heavy levels of cannabis use, both in terms of the number of days used and daily use prior to their most difficult quit attempt, as well as in terms of the average number of blunts smoked by an individual at one time. Additionally, and perhaps most interestingly, no group differences were observed for endorsement of DSM-IV cannabis abuse and/or dependence, which indicates comparable levels of clinical impairment between the two groups. Utilization of formal treatment programs during prior quit attempts was low among both subgroups, indicating that most had tried to quit on their own. This is consistent with the general lack of treatment engagement seen among substance users in the United States, but it is unclear whether this reflects a lack of treatment availability, a stigma associated with seeking treatment in general, or specifically for cannabis use, or a beliefs among this group that initially they would be successful quitting on their own. There are strengths and limitations of this study that warrant acknowledgment. Strengths include: a) the use of identical recruitment strategies and assessments across studies, b) all research volunteers resided and presented for clinical and laboratory cannabis research participation in a single geographic location (greater Baltimore area), c) great degree of overlap with regards to study eligibility criteria, and d) this is the first direct and explicit comparison of cannabis using treatment-versus non-treatment-seeking research volunteers. Limitations of the study include: a) the reliance on retrospective self-report as the primary source of data regarding prior quit attempts, which are subject to recall bias, and b) cross-sectional approach.
Overall, this study provides a better understanding of the comparative characteristics of treatment-and non-treatment-seeking cannabis users than what was previously available. Similar to other examinations of treatment-versus non-treatment-seeking samples of substance users, both similarities and differences were observed. Treatment seekers reported significantly more withdrawal symptoms during abstinence, more reasons for attempting to quit, and utilized a greater number of coping strategies during their most difficult quit attempt, but substance use characteristics between groups were similar. These findings, taken together, potentially characterize treatment-seeking cannabis users as being more motivated to attempt to quit using cannabis than non-treatmentseeking participants, but having more difficulty doing so. Nontreatment-seekers, however, may also benefit from treatment, given that they were found to meet DSM-IV diagnostic criteria for abuse/dependence in comparably high proportions and also reported heavy cannabis use. Group differences based on motivation to quit are particularly noteworthy, given findings from Perkins and Lerman (2014) showing that, among cigarette smokers receiving a nicotine patch, varenicline, or bupropion in Phase 2 studies, treatment for smoking cessation was more effective among smokers who were already high in intrinsic quit motivation, even when given monetary rewards for initiating and maintaining abstinence. In the future, similar research among cannabis users is warranted to assess the importance of intrinsic motivation to quit among participants in research targeting novel treatment development for cannabis use disorders.
